These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7906271)

  • 1. Evidence that proteolytic separation of Shiga-like toxin type IIv A subunit into A1 and A2 subunits is not required for toxin activity.
    Samuel JE; Gordon VM
    J Biol Chem; 1994 Feb; 269(7):4853-9. PubMed ID: 7906271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.
    MacLeod DL; Gyles CL; Valdivieso-Garcia A; Clarke RC
    Infect Immun; 1991 Apr; 59(4):1300-6. PubMed ID: 2004812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the Shiga-like toxin produced by Escherichia coli associated with porcine edema disease.
    Gannon VP; Gyles CL
    Vet Microbiol; 1990 Jul; 24(1):89-100. PubMed ID: 2219668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
    Weinstein DL; Jackson MP; Perera LP; Holmes RK; O'Brien AD
    Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.
    Perera LP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1991 Feb; 173(3):1151-60. PubMed ID: 1991714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
    Weinstein DL; Jackson MP; Samuel JE; Holmes RK; O'Brien AD
    J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of trypsin-like cleavage at arginine 192 in the enzymatic and cytotonic activities of Escherichia coli heat-labile enterotoxin.
    Grant CC; Messer RJ; Cieplak W
    Infect Immun; 1994 Oct; 62(10):4270-8. PubMed ID: 7927684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons.
    Paton AW; Bourne AJ; Manning PA; Paton JC
    Infect Immun; 1995 Jul; 63(7):2450-8. PubMed ID: 7790056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.
    Rüssmann H; Schmidt H; Heesemann J; Caprioli A; Karch H
    J Med Microbiol; 1994 May; 40(5):338-43. PubMed ID: 7909850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
    Lindgren SW; Samuel JE; Schmitt CK; O'Brien AD
    Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli.
    Sung LM; Jackson MP; O'Brien AD; Holmes RK
    J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of the Shiga toxin and Shiga-like toxin type II variant binding subunits by using site-directed mutagenesis.
    Jackson MP; Wadolkowski EA; Weinstein DL; Holmes RK; O'Brien AD
    J Bacteriol; 1990 Feb; 172(2):653-8. PubMed ID: 2404947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli cytotoxins and enterotoxins.
    Gyles CL
    Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the A2 fragment of Shiga-like toxin type I is required for holotoxin integrity.
    Austin PR; Jablonski PE; Bohach GA; Dunker AK; Hovde CJ
    Infect Immun; 1994 May; 62(5):1768-75. PubMed ID: 8168939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolytic cleavage at arginine residues within the hydrophilic disulphide loop of the Escherichia coli Shiga-like toxin I A subunit is not essential for cytotoxicity.
    Burgess BJ; Roberts LM
    Mol Microbiol; 1993 Oct; 10(1):171-9. PubMed ID: 7968513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of processing and intracellular transport for optimal toxicity of Shiga toxin and toxin mutants.
    Garred O; Dubinina E; Holm PK; Olsnes S; van Deurs B; Kozlov JV; Sandvig K
    Exp Cell Res; 1995 May; 218(1):39-49. PubMed ID: 7737376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.
    Melton-Celsa AR; Darnell SC; O'Brien AD
    Infect Immun; 1996 May; 64(5):1569-76. PubMed ID: 8613362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the Shiga toxin and Shiga-like toxin II enzymatic subunits.
    Jackson MP; Deresiewicz RL; Calderwood SB
    J Bacteriol; 1990 Jun; 172(6):3346-50. PubMed ID: 2345150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
    Ohmura M; Cao C; Karasawa T; Okuda J; Kurazono H; Gannon VP; Gyles CL; Takeda Y
    Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic cleavage of the A subunit is essential for maximal cytotoxicity of Escherichia coli O157:H7 Shiga-like toxin-1.
    Lea N; Lord JM; Roberts LM
    Microbiology (Reading); 1999 May; 145 ( Pt 5)():999-1004. PubMed ID: 10376814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.